BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
2.525
-0.005 (-0.20%)
Feb 25, 2026, 4:00 PM EST - Market closed

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Trading of Industrial Chemicals
9.49M9.75M10.83M11.85M11.26M
Trading of Industrial Chemicals Growth
-2.59%-10.03%-8.56%5.25%-
Provision for Genomic Screening Services
16.07K24.22K95.82K1.52M134.10K
Provision for Genomic Screening Services Growth
-33.65%-74.72%-93.68%1030.30%5.62%
Total
9.51M9.77M10.93M13.36M11.39M
Total Growth
-2.66%-10.60%-18.21%17.31%8872.03%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Bangladesh
123.27K538.06K---
Bangladesh Growth
-77.09%----
Malaysia
7.46M8.22M---
Malaysia Growth
-9.32%----
Maldives
762.14K637.19K---
Maldives Growth
19.61%----
Nigeria
-42.07K---
Singapore
572.03K244.40K---
Singapore Growth
134.05%----
Sri Lanka
459.00K87.03K---
Sri Lanka Growth
427.43%----
Indonesia
138.30K----
Total
9.51M9.77M---
Total Growth
-2.66%----
Source: S&P Global Market Intelligence.